Literature DB >> 22903699

Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip.

Ling Xu1, Qingwen Sun, Songmin Jiang, Jia Li, Chongru He, Weidong Xu.   

Abstract

To investigate the pathogenesis of abnormal ossification of the hip ligament in patients with ankylosing spondylitis (AS) by comparing gene expression profiles of the hip ligament in patients with AS to those in normal persons using DNA microarray technology, we studied 18 patients with AS (case group) who underwent total hip arthroplasty in our department from March 1, 2009 to January 31, 2010 and compared them with 6 patients with femoral neck fracture (control group) who underwent total hip replacement. We screened the first five patients in each group with the HumanWG-6 v3.0 Expression BeadChip. Compared to the control group, 519 genes in the case group showed statistically significant differences. Among these, there were 238 upregulated genes and 196 downregulated genes. Gene Ontology (GO) classification showed that differential genes in the hip joint ligaments of patients with AS were involved in immunity, cell adhesion, membrane transport, sugar metabolism, polysaccharide synthesis and metabolism, and cell motility. The Kyoto Encyclopedia of Genes and Genomes classification showed that these differential genes were involved in B cell receptor signaling pathways, adherens junction, protein export, fructose and mannose metabolism, T cell receptor signaling pathways, keratin sulfate biosynthesis, N-glycan biosynthesis, and regulation of the actin cytoskeleton. We tested 2 genes from the screened differential genes in 18 case patients and 6 control cases using real-time polymerase chain reaction. The results demonstrated that the expression of the B4GALT3 gene in the case group was 15.32 times higher than that in the control group (P < 0.01), and the expression of the RBP5 gene in the case group was 4.09 times higher than that in the control group (P < 0.01). This conformed to the microarray analysis. Our preliminary data suggest that differential gene expression in patients with AS includes the immune system, intracellular or extracellular signaling pathway, and bone matrix biosynthesis pathway, which might play important roles in hip joint ligament ossification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22903699     DOI: 10.1007/s10067-012-2038-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.

Authors:  Taras T Antoniv; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2006-09

2.  HES1 cooperates with pRb to activate RUNX2-dependent transcription.

Authors:  Jong-Seo Lee; David M Thomas; Gabriel Gutierrez; Shannon A Carty; Shin-ichi Yanagawa; Philip W Hinds
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 3.  MMPs--role in cardiovascular development and disease.

Authors:  Philip R Brauer
Journal:  Front Biosci       Date:  2006-01-01

4.  [Controlled clinical trials on the pathological expressions of VEGF in patients with active ankylosing spondylitis].

Authors:  Yi-ming Qian; Tong-wei Chu; Jian-ming Li; Yu-gang Liu
Journal:  Zhongguo Gu Shang       Date:  2008-09

5.  [Analysis of inflammation related gene expression spectrum in ankylosing spondylitis patients using cDNA microarray].

Authors:  J Gu; F Huang; D Yu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2001-09-10

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

7.  MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling.

Authors:  Emmanuel George Vrotsos; Pappachan E Kolattukudy; Kiminobu Sugaya
Journal:  Brain Res Bull       Date:  2009-01-29       Impact factor: 4.077

8.  Hes1 stimulates transcriptional activity of Runx2 by increasing protein stabilization during osteoblast differentiation.

Authors:  Jung Hee Suh; Hyun Woo Lee; Joo-Won Lee; Jae Bum Kim
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

9.  A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients.

Authors:  J Gu; E Märker-Hermann; D Baeten; W C Tsai; D Gladman; M Xiong; H Deister; J G Kuipers; F Huang; Y W Song; W Maksymowych; J Kalsi; M Bannai; N Seta; M Rihl; L J Crofford; E Veys; F De Keyser; D T Y Yu
Journal:  Rheumatology (Oxford)       Date:  2002-07       Impact factor: 7.580

10.  Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS.

Authors:  Ran Duan; Paul Leo; Linda Bradbury; Matthew A Brown; Gethin Thomas
Journal:  Ann Rheum Dis       Date:  2009-07-29       Impact factor: 19.103

View more
  7 in total

Review 1.  Expression and Metabolomic Profiling in Axial Spondyloarthritis.

Authors:  Darren D O'Rielly; Guangju Zhai; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2018-06-27       Impact factor: 4.592

2.  Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.

Authors:  Wei Xu; Chao-Ge Liang; Yi-Fan Li; Yun-Han Ji; Wen-Jun Qiu; Xian-Zhong Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.

Authors:  X B Wang; J J Ellis; D J Pennisi; X Song; J Batra; K Hollis; L A Bradbury; Z Li; T J Kenna; M A Brown
Journal:  Genes Immun       Date:  2017-08-24       Impact factor: 2.676

4.  Whole Genome Expression Profiling and Signal Pathway Screening of MSCs in Ankylosing Spondylitis.

Authors:  Yuxi Li; Peng Wang; Zhongyu Xie; Lin Huang; Rui Yang; Liangbin Gao; Yong Tang; Xin Zhang; Jichao Ye; Keng Chen; Zhaopeng Cai; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells Int       Date:  2014-12-03       Impact factor: 5.443

5.  Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology Approaches.

Authors:  Duoli Xie; Lin Huang; Guanghui Zhao; Yiran Yu; Jiawei Gao; Haichang Li; Chengping Wen
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

Review 6.  Genetics and Functional Genomics of Spondyloarthritis.

Authors:  Félicie Costantino; Maxime Breban; Henri-Jean Garchon
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

7.  A Literature Review of Total Hip Arthroplasty in Patients with Ankylosing Spondylitis: Perioperative Considerations and Outcome.

Authors:  S E Putnis; G K Wartemberg; W S Khan; S Agarwal
Journal:  Open Orthop J       Date:  2015-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.